{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:50:30Z","timestamp":1791503430254,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.yrtph.2026.106264","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:16:01Z","timestamp":1790687761000},"page":"106264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Next-generation risk assessment of resveratrol: An external exposure approach based on comprehensive read-across with independent internal exposure verification"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8480-0667","authenticated-orcid":false,"given":"Tomoka","family":"Hisaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Nukaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Atobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetaka","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4110-5015","authenticated-orcid":false,"given":"Morihiko","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/01480545.2021.2015243","article-title":"Biochemical and histopathological analysis after sub-chronic administration of oxyresveratrol in wistar rats","volume":"46","author":"Alam","year":"2023","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106264_bib2","article-title":"Development and application of machine learning models for predicting dermal absorption with consideration of vehicle effects","volume":"2","author":"Atobe","year":"2026","journal-title":"NAMTA J."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/kfaa048","article-title":"A next-generation risk assessment case study for coumarin in cosmetic products","volume":"176","author":"Baltazar","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106264_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104635","article-title":"Piceatannol: a natural stilbene for the prevention and treatment of cancer","volume":"153","author":"Banik","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yrtph.2026.106264_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tox.2017.03.012","article-title":"The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data \u2013 a case study with caffeine","volume":"392","author":"Bessems","year":"2017","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106264_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8090332","article-title":"Human skin lightning efficacy of resveratrol and its analogs: from in vitro studies to cosmetic applications","volume":"8","author":"Boo","year":"2019","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/toxsci\/kfae159","article-title":"Advancing systemic toxicity risk assessment: evaluation of a NAM-Based toolbox approach","volume":"204","author":"Cable","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106264_bib8","series-title":"Pterostilbene Capsules","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106264_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2026.100427","article-title":"Integration of read-across and artificial neural network-based QSAR model for systemic toxicity prediction of mandelic acid","volume":"39","author":"Chaudhari","year":"2026","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106264_bib10","article-title":"Transcriptomic point of departure determination: a comparison of distribution-based and gene set-based approaches","volume":"15\u20132024","author":"Costa","year":"2024","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/toxsci\/kfh263","article-title":"Resveratrol-associated renal toxicity","volume":"82","author":"Crowell","year":"2004","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.addr.2012.01.006","article-title":"Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure","volume":"65","author":"Dancik","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/acs.chemrestox.0c00224","article-title":"GLORYx: prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics","volume":"34","author":"de Bruyn Kops","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106264_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105026","article-title":"Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients","volume":"125","author":"Dent","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106264_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2023.1155645","article-title":"Substantiate a read-across hypothesis by using transcriptome data\u2014A case study on volatile diketones","volume":"5","author":"Drake","year":"2023","journal-title":"Frontiers in Toxicology"},{"key":"10.1016\/j.yrtph.2026.106264_bib16","article-title":"Next generation risk assessment: an ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure","volume":"15\u20132024","author":"Ebmeyer","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106264_bib17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00204-016-1886-5","article-title":"Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment","volume":"91","author":"Farmahin","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106264_bib18","series-title":"Form I: Basic Information on Notified Food Products (Passion GABA)","year":"2023"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2131\/jts.45.95","article-title":"Integration of read-across and artificial neural network-based QSAR models for predicting systemic toxicity: a case study for valproic acid","volume":"45","author":"Hisaki","year":"2020","journal-title":"J. Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106264_bib20","first-page":"264","article-title":"A case study for utilization of next generation risk assessment (NGRA) for the approval of quasi-drugs : predicting the developmental toxicity of 2-Isobutoxyethanol with read-across","volume":"49","author":"Hisaki","year":"2025","journal-title":"Journal of Japanese Cosmetic Science Society"},{"key":"10.1016\/j.yrtph.2026.106264_bib21","series-title":"Compilation of Anatomical, Physiological and Metabolic Characteristics for a Reference Asian Man Volume 2: Country Reports","year":"1998"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106264_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1620\/tjem.128.377","article-title":"Normal cardiac output in relation to age and body size","volume":"128","author":"Katori","year":"1979","journal-title":"Tohoku J. Exp. Med."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106264_bib23","first-page":"183","article-title":"Skin thickness of Korean adults","volume":"24","author":"Lee","year":"2002","journal-title":"Surg. Radiol. Anat."},{"issue":"14","key":"10.1016\/j.yrtph.2026.106264_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144212","article-title":"Oxyresveratrol: sources, productions, biological activities, pharmacokinetics, and delivery systems","volume":"26","author":"Likhitwitayawuid","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106264_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0367-326X(02)00074-6","article-title":"Stilbenes from Sphaerophysa salsula","volume":"73","author":"Ma","year":"2002","journal-title":"Fitoterapia"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106264_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172770","article-title":"Evaluation of 90 day repeated dose oral toxicity and reproductive\/developmental toxicity of 3\u2019-hydroxypterostilbene in experimental animals","volume":"12","author":"Majeed","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.yrtph.2026.106264_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X231198312","article-title":"A short-term safety evaluation of Silbinol\u00ae- an extract from Pterocarpus marsupium in healthy Adults- a randomized, double-blind, placebo-controlled study","volume":"28","author":"Majeed","year":"2023","journal-title":"Journal of Evidence-Based Integrative Medicine"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfac068","article-title":"Are non-animal systemic safety assessments protective? A toolbox and workflow","volume":"189","author":"Middleton","year":"2022","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.yrtph.2026.106264_bib29","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1111\/jdv.16857","article-title":"In vivo characterization of healthy human skin with a novel, non-invasive imaging technique: line-field confocal optical coherence tomography","volume":"34","author":"Monnier","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"12","key":"10.1016\/j.yrtph.2026.106264_bib30","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/rheumatology\/keg435","article-title":"Seventeen-point dermal ultrasound scoring System\u2014A reliable measure of skin thickness in patients with systemic sclerosis","volume":"42","author":"Moore","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.yrtph.2026.106264_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.1082222","article-title":"Article title: transcriptional profiling efficacy to define biological activity similarity for cosmetic ingredients' safety assessment based on next-generation read-across","volume":"4","author":"Naciff","year":"2022","journal-title":"Frontiers in Toxicology"},{"issue":"Number 19","key":"10.1016\/j.yrtph.2026.106264_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196316","article-title":"New insights into dietary pterostilbene: sources, metabolism, and health promotion effects","volume":"27","author":"Nagarajan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.yrtph.2026.106264_bib34","first-page":"14","article-title":"Editorial: advances in and applications of predictive toxicology: 2022","author":"Najjar","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106264_bib35","first-page":"15","article-title":"Development and validation of PBPK models for genistein and daidzein for use in a next-generation risk assessment","author":"Najjar","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106264_bib36","first-page":"1","article-title":"A case study for utilization of next generation risk assessment (NGRA) for the approval of quasi-drugs: predicting the repeated dose toxicity of p-Alkylphenols with read-across","volume":"50","author":"Nakagawa","year":"2026","journal-title":"Journal of Japanese Cosmetic Science Society"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106264_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00004032-199703000-00004","article-title":"A statistical analysis of the internal organ weights of normal Japanese people","volume":"72","author":"Ogiu","year":"1997","journal-title":"Health Phys."},{"key":"10.1016\/j.yrtph.2026.106264_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-statistics-030718-104938","article-title":"Statistical aspects of wasserstein distances","volume":"6","author":"Panaretos","year":"2019","journal-title":"Annual Review Statistics and Its Application"},{"issue":"10","key":"10.1016\/j.yrtph.2026.106264_bib39","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/bioinformatics\/bty878","article-title":"BMDExpress 2: enhanced transcriptomic dose-response analysis workflow","volume":"35","author":"Phillips","year":"2019","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/14764172.2018.1469767","article-title":"Resveratrol as an active ingredient for cosmetic and dermatological applications: a review","volume":"21","author":"Ratz-\u0141yko","year":"2019","journal-title":"J. Cosmet. Laser Ther."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib41","article-title":"Analysis of safety from a human clinical trial with pterostilbene","volume":"2013","author":"Riche","year":"2013","journal-title":"J. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106264_bib42","series-title":"Scientific Committee on Consumer Safety SCCS THE SCCS NOTES OF GUIDANCE FOR THE TESTING OF COSMETIC INGREDIENTS AND THEIR SAFETY EVALUATION 12 TH REVISION","year":"2023"},{"key":"10.1016\/j.yrtph.2026.106264_bib43","series-title":"SCIENTIFIC ADVICE ON HC Yellow No. 16 (Colipa No. B123) (CAS No. 1184721-10-5) Submission II","year":"2024"},{"issue":"12","key":"10.1016\/j.yrtph.2026.106264_bib45","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40262-016-0422-3","article-title":"Development of a whole-body physiologically based pharmacokinetic approach to assess the pharmacokinetics of drugs in elderly individuals","volume":"55","author":"Schlender","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106264_bib46","first-page":"1615","article-title":"Safety evaluation of long-term oral intake of passion fruit seeds extract on healthy Subjects-An open-label Study-","volume":"48","author":"Shimoma","year":"2020","journal-title":"Jpn. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010143","article-title":"Resveratrol and its human metabolites\u2014effects on metabolic health and obesity","volume":"11","author":"Springer","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/01480545.2022.2042014","article-title":"Subacute oral toxicology and toxicokinetics of pterostilbene, a novel Top1\/Tdp1 inhibiting anti-tumor reagent","volume":"46","author":"Sun","year":"2023","journal-title":"Drug Chem. Toxicol."},{"issue":"12","key":"10.1016\/j.yrtph.2026.106264_bib49","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1002\/jps.22726","article-title":"Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions","volume":"100","author":"Thelen","year":"2011","journal-title":"J. Pharmaceut. Sci."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106264_bib50","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.biocel.2005.03.004","article-title":"Pterostilbene and 3\u2032-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells","volume":"37","author":"Tolomeo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jfda.2016.07.004","article-title":"Biological actions and molecular effects of resveratrol, pterostilbene, and 3\u2032-hydroxypterostilbene","volume":"25","author":"Tsai","year":"2017","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.yrtph.2026.106264_bib60","series-title":"Estimation Programs Interface Suite\u2122 for Microsoft\u00ae Windows, v 4.1","year":"2012"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106264_bib52","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/jmf.2012.0025","article-title":"Resveratrol in cholesterol metabolism and atherosclerosis","volume":"15","author":"Voloshyna","year":"2012","journal-title":"J. Med. Food"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib53","first-page":"207","article-title":"Application of high-throughput transcriptomics for mechanism-based biological read-across of short-chain carboxylic acid analogues of valproic acid","volume":"39","author":"Vrijenhoek","year":"2022","journal-title":"ALTEX - Alternatives to Animal Experimentation"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106264_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/toxsci\/kfz205","article-title":"Assessing toxicokinetic uncertainty and variability in risk prioritization","volume":"172","author":"Wambaugh","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106264_bib55","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.fct.2009.06.002","article-title":"Safety studies conducted on high-purity trans-resveratrol in experimental animals","volume":"47","author":"Williams","year":"2009","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106264_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","article-title":"Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs","volume":"34","author":"Willmann","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/17425255.1.1.159","article-title":"From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools","volume":"1","author":"Willmann","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106264_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1478-5382(03)02342-4","article-title":"PK-Sim\u00ae: a physiologically based pharmacokinetic \u2018whole-body\u2019 model","volume":"1","author":"Willmann","year":"2003","journal-title":"Biosilico"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106264_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12514","article-title":"Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1","volume":"52","author":"Zhou","year":"2019","journal-title":"Cell Prolif."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:11:27Z","timestamp":1791501087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026002370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":58,"alternative-id":["S0273230026002370"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106264","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation risk assessment of resveratrol: An external exposure approach based on comprehensive read-across with independent internal exposure verification","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106264"}}